Abstract:Background: Publication of the Women's Health Initiative (WHI) trial results in 2002 significantly reduced physician and patient confidence in and acceptance of hormone replacement therapy (HRT) as an appropriate treatment option for menopause-associated vasomotor symptoms (VMS). This was true despite the fact that the WHI trial was a primary prevention study conducted in postmenopausal women and was not designed to evaluate the efficacy of HRT in the treatment of VMS. Objective: To review data from the WHI, including recent analyses, demonstrating the risks and benefits of HRT in postmenopausal women, to describe changes in menopause treatment guidelines and HRT use since publication of early WHI results nearly 6 years ago, and to identify opportunities for improving the quality of care in perimenopausal women. Summary: Early results from the WHI demonstrated that the risks of longterm HRT in postmenopausal women outweighed the benefits, leading study investigators to conclude that HRT should not be initiated or continued for the primary prevention of coronary heart disease (CHD) in postmenopausal women. Treatment guidelines published by several professional and managed care organizations continue to advocate the use of HRT for treatment of moderate-to-severe VMS. Nevertheless, physician and patient confidence in HRT has declined, as evidenced by a decrease in new HRT prescriptions and an increase in the discontinuation rate of HRT immediately following publication of the preliminary WHI results. Recent analyses demonstrate that the risk for CHD in postmenopausal women is largely dependent upon the age of the woman and the number of years since menopause, with a lower risk for CHD in women aged 50 to 59 years and in women who experienced menopause within the previous 10 years. The highest risk for CHD was evident in women aged 70 to 79 years and in women who experienced menopause 20 or more years ago. Although these data do not support the use of HRT as a primary prevention strategy in postmenopausal women, they do suggest the need to further evaluate the benefits and risks of HRT in perimenopausal women based on patient-specific characteristics, including age and time since menopause. Conclusion: Menopausal women present a unique opportunity for health care providers to improve the quality of care among women, not only as it relates to the treatment of VMS, but also as it relates to osteoporosis and cardiovascular disease, 2 common comorbidities in perimenopausal and postmenopausal women.

Managing the menopause in general practice: a tale of pragmatism, caution, and optimism

Maintaining the menopause momentum

Menopause as a long-term risk to health: implications of general practitioner accounts of prevention for women's choice and decision-making

Menopause as a window of opportunity: the benefits of designing more effective theory-driven behaviour change interventions to promote healthier lifestyle choices at midlife

The 2023 Practitioner's Toolkit for Managing Menopause

Using Digital Health Technologies to Manage the Psychosocial Symptoms of Menopause in the Workplace: A Narrative Literature Review

Effectiveness and safety of menopause treatments: pitfalls of available evidence and future research need

The evolving perspective of menopause management in the United Kingdom

Optimising health after early menopause

Promoting good mental health over the menopause transition

Vision for menopause care in the UK

Understanding Attitudes, Beliefs, and Behaviors Surrounding Menopause Transition: Results from Three Surveys

Minding menopause in patients with cognitive impairment: a patient's perspective and reflections on clinical practice

Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper

Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative

From cardiovascular protection to cardiovascular risk: the metamorphosis of menopausal hormone therapy

Symptoms, health behavior and understanding of menopause therapy in women with premature menopause

Menopause and the workplace: consensus recommendations from The Menopause Society

Menopause and the role of physical activity - The views and knowledge of women aged 40-65

An empowerment model for managing menopause

In search of a well-balanced narrative of the menopause momentum